Previous close | 16.57 |
Open | 20.05 |
Bid | 20.70 x 100 |
Ask | 20.89 x 100 |
Day's range | 19.76 - 21.48 |
52-week range | 13.48 - 37.92 |
Volume | |
Avg. volume | 594,319 |
Market cap | 2.095B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With the business potentially at an important milestone, we thought we'd take a closer look at Zai Lab Limited's...
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize with...
Zai Lab Ltd (NASDAQ:ZLAB), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for cancer, autoimmune, and infectious diseases, has reported an insider sale according to a recent SEC filing.